Stent-based thrombectomy versus intravenous tissue plasminogen activator in patients with acute middle cerebral artery occlusion

Stroke

Volumn 43, Issue 12, 2012, Pages 3389-3391

  Leker, Ronen R ^a   Eichel, Roni ^a   Gomori, John M ^a   De Noriega, Fernando Ramirez ^a   Ben Hur, Tamir ^a   Cohen, Jose E ^a  

^a HADASSAH HEBREW UNIVERSITY MEDICAL CENTER   (Israel)

Author keywords

Endovascular; Ischemia; Stent; Stroke; Thrombectomy

Indexed keywords

TISSUE PLASMINOGEN ACTIVATOR;

ADULT; AGED; ARTICLE; CONTROLLED STUDY; DISABILITY; DISEASE SEVERITY; FEMALE; HOSPITAL ADMISSION; HUMAN; INTERMETHOD COMPARISON; LOGISTIC REGRESSION ANALYSIS; MAJOR CLINICAL STUDY; MALE; MIDDLE CEREBRAL ARTERY OCCLUSION; NATIONAL INSTITUTES OF HEALTH STROKE SCALE; OUTCOME ASSESSMENT; PATIENT IDENTIFICATION; PRIORITY JOURNAL; PROSPECTIVE STUDY; RANKIN SCALE; REGISTER; STENT BASED THROMBECTOMY; THROMBECTOMY; TREATMENT DURATION;

ACUTE DISEASE; AGED; AGED, 80 AND OVER; DISABILITY EVALUATION; FEMALE; FIBRINOLYTIC AGENTS; HUMANS; INFARCTION, MIDDLE CEREBRAL ARTERY; INJECTIONS, INTRAVENOUS; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; REGISTRIES; RETROSPECTIVE STUDIES; SEVERITY OF ILLNESS INDEX; STENTS; THROMBECTOMY; TISSUE PLASMINOGEN ACTIVATOR; TREATMENT OUTCOME;

EID: 84870955351     PISSN: 00392499     EISSN: 15244628     Source Type: Journal    
DOI: 10.1161/STROKEAHA.112.673665     Document Type: Article

References (12)

1. Hacke W, Kaste M, Bluhmki E, Brozman M, Davalos A, Guidetti D, et al. Thrombolysis with alteplase 3 to 4.5 hours after acute ischemic stroke. N Engl J Med. 2008;359:1317-1329.
2. Lees KR, Bluhmki E, von Kummer R, Brott TG, Toni D, Grotta JC, et al. Time to treatment with intravenous alteplase and outcome in stroke: An updated pooled analysis of ECASS, ATLANTIS, NINDS, and EPITHET trials. Lancet. 2010;375:1695-1703.
3. Bhatia R, Hill MD, Shobha N, Menon B, Bal S, Kochar P, et al. Low rates of acute recanalization with intravenous recombinant tissue plasminogen activator in ischemic stroke: Real-world experience and a call for action. Stroke. 2010;41:2254-2258.
4. Castano C, Dorado L, Guerrero C, Millan M, Gomis M, Perez de la Ossa N, et al. Mechanical thrombectomy with the solitaire AB device in large artery occlusions of the anterior circulation: A pilot study. Stroke. 2010;41:1836-1840.
5. Leker RR, Eichel R, Arkadir D, Gomori JM, Raphaeli G, Ben-Hur T, et al. Multi-modal reperfusion therapy for patients with acute anterior circulation stroke in Israel. Stroke. 2009;40:3627-3630.
6. Khatri P, Hill MD, Palesch YY, Spilker J, Jauch EC, Carrozzella JA, et al. Methodology of the Interventional Management of Stroke III Trial. Int J Stroke. 2008;3:130-137.
7. Koh JS, Lee SJ, Ryu CW, Kim HS. Safety and efficacy of mechanical thrombectomy with solitaire stent retrieval for acute ischemic stroke: A systematic review. Neurointervention. 2012;7:1-9.
8. San Roman L, Obach V, Blasco J, Macho J, Lopez A, Urra X, et al. Single-center experience of cerebral artery thrombectomy using the TREVO device in 60 patients with acute ischemic stroke. Stroke. 2012;43:1657-1659.
9. Fischer U, Arnold M, Nedeltchev K, Brekenfeld C, Ballinari P, Remonda L, et al. NIHSS score and arteriographic findings in acute ischemic stroke. Stroke. 2005;36:2121-2125.
10. Barber PA, Demchuk AM, Zhang J, Buchan AM. Validity and reliability of a quantitative computed tomography score in predicting outcome of hyperacute stroke before thrombolytic therapy. ASPECTS Study Group. Alberta Stroke Programme Early CT Score. Lancet. 2000;355:1670-1674.
11. Vora NA, Shook SJ, Schumacher HC, Tievsky AL, Albers GW, Wechsler LR, et al. A 5-item scale to predict stroke outcome after cortical middle cerebral artery territory infarction: Validation from results of the Diffusion and Perfusion Imaging Evaluation for Understanding Stroke Evolution (DEFUSE) Study. Stroke. 2011;42:645-649.
12. Rha JH, Saver JL. The impact of recanalization on ischemic stroke outcome: A meta-analysis. Stroke. 2007;38:967-973.